Hospital procedure volume and prognosis with respect to testicular cancer patients: A population-based study in Osaka, Japan

Cancer Science

Volumn 99, Issue 11, 2008, Pages 2260-2263

  Suzumura, Shigeo ^a   Ioka, Akiko ^a   Nakayama, Tomio ^a   Tsukuma, Hideaki ^a   Oshima, Akira ^b   Ishikawa, Osamu ^c  

^a Cancer Control and Statistics   (Japan)

^b Cancer Patients Information Services   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CENTRALIZATION; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; GERM CELL TUMOR; HISTOPATHOLOGY; HOSPITAL CARE; HOSPITAL ORGANIZATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TESTIS CANCER; TREND STUDY;

HOSPITAL MORTALITY; HOSPITALS; HUMANS; JAPAN; MALE; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; SURVIVAL RATE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 55449104408     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00920.x     Document Type: Article

References (15)

1. Einhorn LH, Donouhue J. cis-Diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977; 87: 293-8.
2. Motzer RJ, Scheinfeld J, Mazumdar M et al. Paclitaxel, ifosfamide, and cisplatin second-Line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol 2000; 18: 2413-8.
3. Mencel PJ, Motzer RJ, Mazumdar M, Vlamis V, Bajorin DF, Bosl GJ. Advanced seminoma: Treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol 1994; 12: 120-6 (1994 deleted).
4. Hain SF, O's Doherty MJ. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer 2000; 83: 863-9.
5. Ries LAG, Eisner MP, Kosary CL et al. SEER Cancer Statistics Review, 1973-98. Bethesda, MD: National Cancer Institute, 2001.
6. Oshima A, Kitagawa T, Ajiki W, Tsukuma H, Takenaka S, Iura A. Survival of testicular cancer patients in Osaka Japan. Jpn J Clin Oncol 2001; 31: 438-43.
7. Berrino F, Angelis RD, Sant M et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the Eurocare-4 study. Oncol Lancet Com 2007; 8: 773-83.
8. Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research, Vol. IV Descriptive Epidemiology. Lyon: IARC, 1994; 231-45.
9. Editors in Japan National Cancer Center. Survival probability table. [Cited 20 March 2008.] Available from URL: http://ganjoho.ncc.go.jp/ professional/statistics/cohort01.html/
10. Akaike H, Amari T, Kitagawa G, Shimohira H. Akaike's Information Criterion (AIC) [in Japanese]. Tokyo: Kyoritsu-syuppan, 2007.
11. Uwafuji I, Morimoto E, Tsunekane M. Statistics for Investigation and Analysis [in Japanese]. Tokyo: Maruzen, 2006.
12. Editors in USA. National Cancer Institute. Surveillance Epidemiology and End Results Cancer Statistics Review. [Cited 20 March 2008.]Available from URL: http://seer.cancer.gov/csr/1975_2004/
13. Ioka A, Tsukuma H, Ajiki W, Oshima A. Hospital procedure volume and survival of cancer patients in Osaka, Japan: A population-based study with latest cases. Jpn J Clin Oncol 2007; 37: 544-53.
14. Brenner H, Hakulinen T. Period versus cohort modeling of up-to-date cancer survival. Int J Cancer 2007; 122: 898-904.
15. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents, Vol. III. Lyon: IARC, 2003: 264-5.